Evidence map›Paper›PMID 42179583›Full record

ArticleACS omega2026

Thermally Activated Vaporization of Fluorocarbon-In-Hydrocarbon Exoskeletal Droplets.

William N Frantz, Awaneesh Upadhyay, Mark A Borden

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

William N FrantzBiomedical Engineering Program, University of Colorado, Boulder, Colorado 80309, United States.
Awaneesh UpadhyayDepartment of Mechanical Engineering, University of Colorado, Boulder, Colorado 80309, United States.
Mark A BordenBiomedical Engineering Program, University of Colorado, Boulder, Colorado 80309, United States.ORCID https://orcid.org/0000-0002-2089-983X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prior research has demonstrated synthesis and vaporization of hydrocarbon (HC)-in-fluorocarbon (H/F/W) endoskeletal droplets in aqueous suspension through the use of a fluorosurfactant and their potential utility as photoacoustic contrast agents. Here, we describe the synthesis of novel fluorocarbon-in-hydrocarbon (F/H/W) exoskeletal droplets through the choice of phospholipid surfactant. Exoskeletal drops tended to form nonspherical structures due to the elasticity of the solid HC shell. Vaporization of exoskeletal droplets occurred over a longer time scale than endoskeletal droplets due to constricted vapor nucleation and growth, and the resulting bubbles were significantly smaller. The size distribution of the exoskeletal droplets and the resulting bubbles could be further reduced through filtration. In contrast to endoskeletal droplets, which rapidly vaporized from a single nucleation site, exoskeletal droplets formed multiple nucleation sites during vaporization. Heat treatment with quenching increased the number of nucleation sites on each vaporizing droplet. The improved biocompatibility and ability to control the process of vaporization for exoskeletal droplets may be advantageous for medical imaging and other applications.

Identifiers

PMID42179583
PMCPMC13191537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.